Cholangiocarcinoma—or biliary duct cancer—affects about 8000 US patients a year. On this episode of Managed Care Cast, we bring you an excerpt of an interview with Jesper B. Andersen, PhD, associate professor and group leader at the University of Copenhagen and the Biotech Research and Innovation center at the Department of Health.


There have been 3 FDA drug approvals for drugs that treat cholangiocarcinoma, but only for patients that have certain mutations or rearrangements, signifying an unmet need, noted Andersen. And due to the limited number of patients, clinical trials are challenging. 


Dr Anderson spoke recently with Brielle Benyon, senior editor of CURE®, a publication by MJH Life Sciences. 

You can watch this interview and many others with by Visiting Medicalworldnews.com, where you can get expert insights you won’t find anywhere else.

Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer

Science

On this episode of Managed Care Cast, we're talking with Illinois CancerCare's Pankaj Kumar, MD, and Stephanie Parker, PharmD, 2 authors of a commentary published in the May 2024 issue of The American Journal of Managed Care.

Their commentary, "Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America," discusses how recent CMS rules restricted the access of rural patients with cancer to medically integrated pharmacies, emphasizing the need for regulatory change.

Cancer Care Crisis: Experts Discuss CMS Restrictions Impacting Rural Patients With Cancer

In the series debut episode of Frameworks for Advancing Health Equity, Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.

Frameworks for Advancing Health Equity: Urban Health Outreach

On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega. We discussed CMS's recent Medicare Part D and Medicare Advantage final rule and how it affects enrollees and health plans.

CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection

To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.

Tackling Health Inequality: The Power of Education and Experience

On this episode of Managed Care Cast, we're talking with the University of Pennsylvania's Ravi Parikh, MD, MPP, and Aaron Schwartz, MD, PhD, 2 authors of a study published in the April 2024 issue of The American Journal of Managed Care®.

Their study, "Trends in Low-Value Cancer Care During the COVID-19 Pandemic," discusses how rates of low-value cancer services among adults with newly diagnosed cancer persisted throughout the COVID-19 pandemic.

Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer

Download our free app to listen on your phone